Global Vaccines for the Elderly Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Vaccines for the Elderly Market Overview

1.1 Vaccines for the Elderly Definition

1.2 Global Vaccines for the Elderly Market Size Status and Outlook (2019-2032)

1.3 Global Vaccines for the Elderly Market Size Comparison by Region (2019-2032)

1.4 Global Vaccines for the Elderly Market Size Comparison by Type (2019-2032)

1.5 Global Vaccines for the Elderly Market Size Comparison by Application (2019-2032)

1.6 Global Vaccines for the Elderly Market Size Comparison by Sales Channel (2019-2032)

1.7 Vaccines for the Elderly Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Vaccines for the Elderly Market Snapshot

2.2 Global Vaccines for the Elderly Market Volume & Revenue (2019-2025)

2.3 Global Vaccines for the Elderly Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Vaccines for the Elderly Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Vaccines for the Elderly Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Vaccines for the Elderly Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Vaccines for the Elderly Market Segment Analysis by Player

3.1 Global Vaccines for the Elderly Sales and Market Share by Player (2023-2025)

3.2 Global Vaccines for the Elderly Revenue and Market Share by Player (2023-2025)

3.3 Global Vaccines for the Elderly Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Vaccines for the Elderly Market Segment Analysis by Type

4.1 Global Vaccines for the Elderly Market by Type

4.1.1 Flu Vaccine

4.1.2 Respiratory Syncytial Virus (RSV) Vaccine

4.1.3 Recombinant Herpes Zoster Vaccine

4.1.4 23-Valent Pneumococcal Polysaccharide Vaccine

4.1.5 Others

4.2 Global Vaccines for the Elderly Sales and Market Share by Type (2019-2025)

4.3 Global Vaccines for the Elderly Revenue and Market Share by Type (2019-2025)

4.4 Global Vaccines for the Elderly Average Price by Type (2019-2025)

4.5 Leading Players of Vaccines for the Elderly by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Vaccines for the Elderly Market Segment Analysis by Application

5.1 Global Vaccines for the Elderly Market by Application

5.1.1 Hospital

5.1.2 Clinic

5.1.3 Public Health Agency

5.1.4 Others

5.2 Global Vaccines for the Elderly Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Vaccines for the Elderly by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Vaccines for the Elderly Market Segment Analysis by Sales Channel

6.1 Global Vaccines for the Elderly Market by Sales Channel

6.1.1 Global Vaccines for the Elderly Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Vaccines for the Elderly Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Vaccines for the Elderly Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Vaccines for the Elderly by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Vaccines for the Elderly Market Segment Analysis by Region

7.1 Global Vaccines for the Elderly Market Size and CAGR by Region (2019-2032)

7.2 Global Vaccines for the Elderly Sales and Market Share by Region (2019-2025)

7.3 Global Vaccines for the Elderly Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Vaccines for the Elderly Market Share by Type

7.4.3 North America Vaccines for the Elderly Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Vaccines for the Elderly Market Share by Type

7.5.3 Europe Vaccines for the Elderly Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Vaccines for the Elderly Market Share by Type

7.6.3 Asia-Pacific Vaccines for the Elderly Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Vaccines for the Elderly Market Share by Type

7.7.3 South America Vaccines for the Elderly Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Vaccines for the Elderly Market Share by Type

7.8.3 Middle East & Africa Vaccines for the Elderly Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Vaccines for the Elderly Players

8.1 Pfizer

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 GSK

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Merck

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 CSL

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Sanofi

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 AstraZeneca

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Hualan Bio

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Sinovac

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Kangtai Bio

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 CDIBP

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Walvax

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Vaccines for the Elderly

9.1 Industrial Chain of Vaccines for the Elderly

9.2 Upstream of Vaccines for the Elderly

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Vaccines for the Elderly

9.3.1 Leading Distributors/Dealers of Vaccines for the Elderly

9.3.2 Leading Consumers of Vaccines for the Elderly

Chapter 10. Global Vaccines for the Elderly Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Vaccines for the Elderly Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Vaccines for the Elderly Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Vaccines for the Elderly (2026-2032)

11.1 Global Vaccines for the Elderly Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Vaccines for the Elderly Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Vaccines for the Elderly Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Vaccines for the Elderly Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Vaccines for the Elderly Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Vaccines for the Elderly Import-Export (2019-2025)

12.2 Europe Vaccines for the Elderly Import-Export (2019-2025)

12.3 Asia Pacific Vaccines for the Elderly Import-Export (2019-2025)

12.4 South America Vaccines for the Elderly Import-Export (2019-2025)

12.5 Middle East & Africa Vaccines for the Elderly Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Vaccines for the Elderly Demand-Supply (2019-2025)

13.2 Europe Vaccines for the Elderly Demand-Supply (2019-2025)

13.3 Asia Pacific Vaccines for the Elderly Demand-Supply (2019-2025)

13.4 South America Vaccines for the Elderly Demand-Supply (2019-2025)

13.5 Middle East & Africa Vaccines for the Elderly Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources